Literature DB >> 17049678

Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides.

Joe Inoue1, Yukihiko Aramaki.   

Abstract

Recently, there has been a lot of interest in the potential of non-invasive routes, such as via the skin, for vaccine delivery. CpG-oligodeoxynucleotides (ODN) are an effective adjuvant for the induction of cellular and humoral immunities when administered with an antigen. We demonstrated here that tape-stripping induces the expression of toll-like receptor (TLR)-9 in the skin, and enhances the Th1-type immune response triggered by CpG-ODN administered through the tape-stripped skin. Tape-stripping induces expression of TLR-9 and tumor necrosis factor (TNF)-alpha in the skin, and CpG-ODN treatment through the tape-stripped skin enhances the migration of antigen presenting cells (APCs) to the draining lymph nodes. On the other hand, TLR-9 mRNA and TNF-alpha mRNA were not observed in the skin when CpG-ODN was injected intradermally in a volume of 10 microL, or in a Th1-type immune response. The transdermal application of CpG-ODN with an antigen through the tape-stripped skin is an effective way to induce a Th1-type immune response, and is also a simple, cost-effective and needle-free vaccination system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049678     DOI: 10.1016/j.vaccine.2006.09.075

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

Review 1.  In vivo methods for the assessment of topical drug bioavailability.

Authors:  Christophe Herkenne; Ingo Alberti; Aarti Naik; Yogeshvar N Kalia; François-Xavier Mathy; Véronique Préat; Richard H Guy
Journal:  Pharm Res       Date:  2007-11-06       Impact factor: 4.200

2.  Effect of tape stripping and adjuvants on immune response after intradermal DNA electroporation.

Authors:  Gaëlle Vandermeulen; Liévin Daugimont; Hervé Richiardi; Marie-Lise Vanderhaeghen; Nathalie Lecouturier; Bernard Ucakar; Véronique Préat
Journal:  Pharm Res       Date:  2009-04-21       Impact factor: 4.200

Review 3.  Langerhans cells as targets for immunotherapy against skin cancer.

Authors:  Patrizia Stoitzner; Florian Sparber; Christoph H Tripp
Journal:  Immunol Cell Biol       Date:  2010-03-30       Impact factor: 5.126

4.  Intradermal immunization of mice with radiation-attenuated sporozoites of Plasmodium yoelii induces effective protective immunity.

Authors:  Tatiana Voza; Chahnaz Kebaier; Jerome P Vanderberg
Journal:  Malar J       Date:  2010-12-15       Impact factor: 2.979

Review 5.  Delivery systems for intradermal vaccination.

Authors:  Y C Kim; C Jarrahian; D Zehrung; S Mitragotri; M R Prausnitz
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 6.  Skin as an immune organ and clinical applications of skin-based immunotherapy.

Authors:  J Andrew Bird; Mario Sánchez-Borges; Ignacio J Ansotegui; Motohiro Ebisawa; José Antonio Ortega Martell
Journal:  World Allergy Organ J       Date:  2018-12-07       Impact factor: 4.084

7.  Liposomal lipopolysaccharide initiates TRIF-dependent signaling pathway independent of CD14.

Authors:  Sachiko Watanabe; Yoshio Kumazawa; Joe Inoue
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

8.  Intracellular delivery of lipopolysaccharide induces effective Th1-immune responses independent of IL-12.

Authors:  Sachiko Watanabe; Joe Inoue
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

Review 9.  Transcutaneous antigen delivery system.

Authors:  Mi-Young Lee; Meong-Cheol Shin; Victor C Yang
Journal:  BMB Rep       Date:  2013-01       Impact factor: 4.778

10.  Gua Sha, a press-stroke treatment of the skin, boosts the immune response to intradermal vaccination.

Authors:  Tingting Chen; Ninghua Liu; Jinxuan Liu; Xiaoying Zhang; Zhen Huang; Yuhui Zang; Jiangning Chen; Lei Dong; Junfeng Zhang; Zhi Ding
Journal:  PeerJ       Date:  2016-09-14       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.